Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults	Bone Diseases, Metabolic, Critical Illness, Disease Attributes, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis	Recruiting	Phase 2	2026-03-04		NCT04608630

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Australian and New Zealand Intensive Care Research Centre	20

22 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Alfred Health	Melbourne	Australia	32
Auckland City Hospital	Auckland	New Zealand	68
Austin Health	Melbourne	Australia	16
Barwon Health, University Hospital Geelong	Geelong	Australia	2
Blacktown Hospital	Sydney	Australia	4
Eastern Health - Box Hill Hospital	Melbourne	Australia	3
Fiona Stanley Hospital	Perth	Australia	16
Gold Coast University Hospital	Southport	Australia	35
Prince of Wales Hospital	Sydney	Australia	12
Royal Adelaide Hospital	Adelaide	Australia	132
Royal Melbourne Hospital	Melbourne	Australia	7
Royal Prince Alfred Hospital	Sydney	Australia	4
St John of God Hospital Murdoch	Perth	Australia	1
St John of God Hospital Subiaco	Perth	Australia	1
St Vincent's Health Sydney	Sydney	Australia	2
St Vincents Hospital Melbourne	Melbourne	Australia	3
Sunshine Coast University Hospital	Birtinya	Australia	34
The Wesley Hospital	Brisbane	Australia	2
Wellington Regional Hospital	Wellington	New Zealand	5
Western Health - Footscray Hospital	Melbourne	Australia	1
Western Health - Sunshine Hospital	Melbourne	Australia	2
Wollongong Hospital, Illawarra Shoalhaven Health	Wollongong	Australia	1

Clinical trials